Sai Life Sciences Limited (NSE:SAILIFE)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Contract Research, Development and Manufacturing Activities	14.69B
Contract Research, Development and Manufacturing Activities Growth	22.71%
Export Incentives	1.45M
Production Linked Incentive	-36.90M
Production Linked Incentive Growth	-118.28%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
International	14.39B
International Growth	22.31%
India	301.21M
India Growth	45.11%